
Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs
Medicare Part D beneficiaries would have experienced a 63% reduction in out-of-pocket spending if the Medicare $2 drug list model had been in place in 2021, according to a research letter published today in JAMA.1 The researchers highlighted that generic …